The brain mapping instruments market size has grown strongly in recent years. It will grow from $2.42 billion in 2025 to $2.58 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to growth in neurological disorder diagnosis programs, increasing utilization of eeg and ct-based brain mapping systems, early adoption of neuroimaging tools in hospital and research centers, expansion of brain activity monitoring in clinical neurology, rising investment in neuroscience research infrastructure.
The brain mapping instruments market size is expected to see strong growth in the next few years. It will grow to $3.33 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising demand for fmri and pet-based functional brain mapping, increasing uptake of hybrid and high-resolution imaging systems, higher adoption of non-invasive mapping solutions in ambulatory settings, growing integration of multimodal brain analysis tools, expanding application of brain mapping in precision medicine and neurotherapeutics. Major trends in the forecast period include increasing adoption of advanced neuroimaging and brain activity monitoring technologies, growing use of brain mapping instruments in clinical diagnosis and treatment planning, expansion of brain mapping applications in neuroscience and cognitive research, rising preference for non-invasive and patient-friendly brain mapping procedures, focus on enhancing imaging accuracy, data quality, and diagnostic efficiency.
The rising prevalence of neurological disorders is expected to drive the growth of the brain mapping instrument market in the coming years. Neurological disorders are conditions impacting the brain, spinal cord, and nerves, leading to symptoms such as movement difficulties, cognitive decline, and sensory impairments, with examples including Alzheimer’s, Parkinson’s, epilepsy, multiple sclerosis, and stroke. The increase in neurological disorders is attributed to factors such as an aging population, urbanization, lifestyle shifts, advancements in diagnostic technologies, and various environmental and infectious risk factors. Brain mapping instruments play a crucial role in both clinical practice and research, providing valuable insights into neurological conditions and supporting personalized treatment approaches. For example, in March 2023, the Alzheimer’s Association, a U.S.-based nonprofit health organization, reported that approximately 6.7 million Americans aged 65 and older were living with Alzheimer’s dementia, a neurological disorder. Furthermore, the number of Americans aged 65 and older with Alzheimer’s dementia is projected to rise to 13.8 million by 2060. Thus, the increasing prevalence of neurological disorders is propelling the growth of the brain mapping instrument market.
Major companies operating in the brain mapping instruments market are focusing on sensing-enabled adaptive neuromodulation, such as BrainSense-enabled closed-loop deep brain stimulation (DBS), to deliver more precise and personalized neurological therapy. Sensing-enabled adaptive neuromodulation systems integrate real-time brain signal detection with stimulation delivery, allowing therapy to dynamically respond to a patient’s neural activity. BrainSense technology is a neuro-interface embedded in DBS systems that records local field potentials (LFPs) from targeted brain regions, analyzes these signals, and automatically adjusts stimulation parameters in real time. This closed-loop approach helps optimize therapeutic outcomes while minimizing side effects associated with overstimulation. For instance, in February 2025, Medtronic, a US-based medical technology company, introduced its BrainSense Adaptive DBS system following FDA approval. The system features real-time self-adjusting stimulation, a BrainSense Electrode Identifier that rapidly determines the optimal electrode contact, and personalized closed-loop therapy that adapts both in clinical environments and during patients’ daily activities, enhancing treatment precision and quality of life for individuals with neurological disorders.
In May 2025, Firefly Neuroscience, Inc., a US-based artificial intelligence company developing brain-health solutions, acquired Evoke Neuroscience, Inc. for approximately US$6 million, comprising 50% cash, 50% Firefly common stock, and up to an additional US$0.5 million in earn-out payments. With this acquisition, Firefly significantly expanded its proprietary brain-wave (EEG/ERP) data assets, intellectual property portfolio, and commercial presence, strengthening its ability to accelerate the development of a foundational AI model of the human brain. Evoke Neuroscience, Inc. is a US-based medical device company that provides FDA-cleared hardware and software platforms for comprehensive EEG and event-related potential (ERP)-based brain health assessments.
Major companies operating in the brain mapping instruments market are Siemens Healthineers, GE Healthcare, Philips Healthcare, Elekta AB, Nihon Kohden Corporation, Brainlab AG, Natus Medical Incorporated, Hitachi Medical Systems, Canon Medical Systems Corporation, Compumedics Limited, Medtronic PLC, Magstim Company Limited, EB Neuro S.p.A., Brain Products GmbH, Soterix Medical Inc., Rogue Research Inc., NIRx Medical Technologies LLC, Neurosoft, Artinis Medical Systems, Gowerlabs Ltd.
North America was the largest region in the brain mapping instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain mapping instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brain mapping instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are affecting the brain mapping instruments market by increasing import costs for imaging hardware, electronic assemblies, detector modules, superconducting magnets, and precision optical components that are sourced globally for ct, pet, eeg, fnirs, and fmri systems. The financial impact is particularly visible across high-field mri platforms, hybrid pet/ct scanners, and advanced eeg systems manufactured in North America, Europe, and Asia-Pacific technology hubs that rely on cross-border component supply. Hospitals and ambulatory centers are experiencing longer procurement cycles, price revisions, and budget constraints as tariff-driven cost escalations move across OEMs and distributors. At the same time, tariffs are encouraging regional manufacturing partnerships, localized component production, and domestic assembly initiatives, which may improve long-term supply resilience and ecosystem competitiveness.
The brain mapping instruments market research report is one of a series of new reports that provides brain mapping instruments market statistics, including brain mapping instruments industry global market size, regional shares, competitors with a brain mapping instruments market share, detailed brain mapping instruments market segments, market trends and opportunities, and any further data you may need to thrive in the brain mapping instruments industry. This brain mapping instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A brain mapping instrument is a device designed to visualize, measure, and analyze both the structure and function of the brain. Utilizing various technologies, these instruments offer detailed images and data on brain activity, connectivity, and anatomy. They play a crucial role in neuroscience research, clinical diagnosis, and treatment planning.
Key products in brain mapping include computed axial tomography (CAT), positron emission tomography, electroencephalography (EEG), functional near-infrared spectroscopy (fNIRS), and functional magnetic resonance imaging (fMRI). Computed Axial Tomography (CAT), also known as Computed Tomography (CT), is an advanced imaging technique that employs X-rays and computer processing to create highly detailed cross-sectional images of the body's internal structures. This technique is a significant diagnostic tool in modern healthcare. The available procedures encompass both invasive and non-invasive devices, serving various end users such as hospitals and ambulatory centers.
The brain mapping instruments market consists of sales of electroencephalography (EEG) systems, magnetoencephalography (MEG) systems, near-infrared spectroscopy (NIRS) systems, magnetic resonance spectroscopy (MRS) systems, and optogenetics tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The brain mapping instruments market size is expected to see strong growth in the next few years. It will grow to $3.33 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising demand for fmri and pet-based functional brain mapping, increasing uptake of hybrid and high-resolution imaging systems, higher adoption of non-invasive mapping solutions in ambulatory settings, growing integration of multimodal brain analysis tools, expanding application of brain mapping in precision medicine and neurotherapeutics. Major trends in the forecast period include increasing adoption of advanced neuroimaging and brain activity monitoring technologies, growing use of brain mapping instruments in clinical diagnosis and treatment planning, expansion of brain mapping applications in neuroscience and cognitive research, rising preference for non-invasive and patient-friendly brain mapping procedures, focus on enhancing imaging accuracy, data quality, and diagnostic efficiency.
The rising prevalence of neurological disorders is expected to drive the growth of the brain mapping instrument market in the coming years. Neurological disorders are conditions impacting the brain, spinal cord, and nerves, leading to symptoms such as movement difficulties, cognitive decline, and sensory impairments, with examples including Alzheimer’s, Parkinson’s, epilepsy, multiple sclerosis, and stroke. The increase in neurological disorders is attributed to factors such as an aging population, urbanization, lifestyle shifts, advancements in diagnostic technologies, and various environmental and infectious risk factors. Brain mapping instruments play a crucial role in both clinical practice and research, providing valuable insights into neurological conditions and supporting personalized treatment approaches. For example, in March 2023, the Alzheimer’s Association, a U.S.-based nonprofit health organization, reported that approximately 6.7 million Americans aged 65 and older were living with Alzheimer’s dementia, a neurological disorder. Furthermore, the number of Americans aged 65 and older with Alzheimer’s dementia is projected to rise to 13.8 million by 2060. Thus, the increasing prevalence of neurological disorders is propelling the growth of the brain mapping instrument market.
Major companies operating in the brain mapping instruments market are focusing on sensing-enabled adaptive neuromodulation, such as BrainSense-enabled closed-loop deep brain stimulation (DBS), to deliver more precise and personalized neurological therapy. Sensing-enabled adaptive neuromodulation systems integrate real-time brain signal detection with stimulation delivery, allowing therapy to dynamically respond to a patient’s neural activity. BrainSense technology is a neuro-interface embedded in DBS systems that records local field potentials (LFPs) from targeted brain regions, analyzes these signals, and automatically adjusts stimulation parameters in real time. This closed-loop approach helps optimize therapeutic outcomes while minimizing side effects associated with overstimulation. For instance, in February 2025, Medtronic, a US-based medical technology company, introduced its BrainSense Adaptive DBS system following FDA approval. The system features real-time self-adjusting stimulation, a BrainSense Electrode Identifier that rapidly determines the optimal electrode contact, and personalized closed-loop therapy that adapts both in clinical environments and during patients’ daily activities, enhancing treatment precision and quality of life for individuals with neurological disorders.
In May 2025, Firefly Neuroscience, Inc., a US-based artificial intelligence company developing brain-health solutions, acquired Evoke Neuroscience, Inc. for approximately US$6 million, comprising 50% cash, 50% Firefly common stock, and up to an additional US$0.5 million in earn-out payments. With this acquisition, Firefly significantly expanded its proprietary brain-wave (EEG/ERP) data assets, intellectual property portfolio, and commercial presence, strengthening its ability to accelerate the development of a foundational AI model of the human brain. Evoke Neuroscience, Inc. is a US-based medical device company that provides FDA-cleared hardware and software platforms for comprehensive EEG and event-related potential (ERP)-based brain health assessments.
Major companies operating in the brain mapping instruments market are Siemens Healthineers, GE Healthcare, Philips Healthcare, Elekta AB, Nihon Kohden Corporation, Brainlab AG, Natus Medical Incorporated, Hitachi Medical Systems, Canon Medical Systems Corporation, Compumedics Limited, Medtronic PLC, Magstim Company Limited, EB Neuro S.p.A., Brain Products GmbH, Soterix Medical Inc., Rogue Research Inc., NIRx Medical Technologies LLC, Neurosoft, Artinis Medical Systems, Gowerlabs Ltd.
North America was the largest region in the brain mapping instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain mapping instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brain mapping instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are affecting the brain mapping instruments market by increasing import costs for imaging hardware, electronic assemblies, detector modules, superconducting magnets, and precision optical components that are sourced globally for ct, pet, eeg, fnirs, and fmri systems. The financial impact is particularly visible across high-field mri platforms, hybrid pet/ct scanners, and advanced eeg systems manufactured in North America, Europe, and Asia-Pacific technology hubs that rely on cross-border component supply. Hospitals and ambulatory centers are experiencing longer procurement cycles, price revisions, and budget constraints as tariff-driven cost escalations move across OEMs and distributors. At the same time, tariffs are encouraging regional manufacturing partnerships, localized component production, and domestic assembly initiatives, which may improve long-term supply resilience and ecosystem competitiveness.
The brain mapping instruments market research report is one of a series of new reports that provides brain mapping instruments market statistics, including brain mapping instruments industry global market size, regional shares, competitors with a brain mapping instruments market share, detailed brain mapping instruments market segments, market trends and opportunities, and any further data you may need to thrive in the brain mapping instruments industry. This brain mapping instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A brain mapping instrument is a device designed to visualize, measure, and analyze both the structure and function of the brain. Utilizing various technologies, these instruments offer detailed images and data on brain activity, connectivity, and anatomy. They play a crucial role in neuroscience research, clinical diagnosis, and treatment planning.
Key products in brain mapping include computed axial tomography (CAT), positron emission tomography, electroencephalography (EEG), functional near-infrared spectroscopy (fNIRS), and functional magnetic resonance imaging (fMRI). Computed Axial Tomography (CAT), also known as Computed Tomography (CT), is an advanced imaging technique that employs X-rays and computer processing to create highly detailed cross-sectional images of the body's internal structures. This technique is a significant diagnostic tool in modern healthcare. The available procedures encompass both invasive and non-invasive devices, serving various end users such as hospitals and ambulatory centers.
The brain mapping instruments market consists of sales of electroencephalography (EEG) systems, magnetoencephalography (MEG) systems, near-infrared spectroscopy (NIRS) systems, magnetic resonance spectroscopy (MRS) systems, and optogenetics tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Brain Mapping Instruments Market Characteristics
3. Brain Mapping Instruments Market Supply Chain Analysis
4. Global Brain Mapping Instruments Market Trends and Strategies
5. Brain Mapping Instruments Market Analysis of End Use Industries
7. Global Brain Mapping Instruments Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Brain Mapping Instruments Total Addressable Market (TAM) Analysis for the Market
9. Brain Mapping Instruments Market Segmentation
10. Brain Mapping Instruments Market Regional and Country Analysis
11. Asia-Pacific Brain Mapping Instruments Market
12. China Brain Mapping Instruments Market
13. India Brain Mapping Instruments Market
14. Japan Brain Mapping Instruments Market
15. Australia Brain Mapping Instruments Market
16. Indonesia Brain Mapping Instruments Market
17. South Korea Brain Mapping Instruments Market
18. Taiwan Brain Mapping Instruments Market
19. South East Asia Brain Mapping Instruments Market
20. Western Europe Brain Mapping Instruments Market
21. UK Brain Mapping Instruments Market
22. Germany Brain Mapping Instruments Market
23. France Brain Mapping Instruments Market
24. Italy Brain Mapping Instruments Market
25. Spain Brain Mapping Instruments Market
26. Eastern Europe Brain Mapping Instruments Market
27. Russia Brain Mapping Instruments Market
28. North America Brain Mapping Instruments Market
29. USA Brain Mapping Instruments Market
30. Canada Brain Mapping Instruments Market
31. South America Brain Mapping Instruments Market
32. Brazil Brain Mapping Instruments Market
33. Middle East Brain Mapping Instruments Market
34. Africa Brain Mapping Instruments Market
36. Brain Mapping Instruments Market Competitive Landscape and Company Profiles
37. Brain Mapping Instruments Market Other Major and Innovative Companies
40. Brain Mapping Instruments Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Brain Mapping Instruments Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses brain mapping instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for brain mapping instruments? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The brain mapping instruments market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Computed Axial Tomography (CAT); Positron Emission Tomography; Electroencephalography (EEG); Functional Near-Infrared Spectroscopy (FNIRS); Functional Magnetic Resonance Imaging (FMRI); Other Products2) By Procedure: Devices For Invasive Procedures; Devices For Non-invasive Procedures
3) By End User: Hospitals; Ambulatory Centers
Subsegments:
1) By Computed Axial Tomography (CAT): Conventional CT Scanners; High-Resolution CT Scanners; Portable CT Scanners2) By Positron Emission Tomography (PET): PET Scanners (Standalone); Hybrid PET/CT Scanners; PET/MRI Scanners
3) By Electroencephalography (EEG): Digital EEG Systems; Ambulatory EEG Systems; Video EEG Monitoring Systems
4) By Functional Near-Infrared Spectroscopy (FNIRS): Continuous Wave Fnirs Systems; Frequency Domain Fnirs Systems; Hybrid Fnirs Systems
5) By Functional Magnetic Resonance Imaging (FMRI): Resting-State Fmri; Task-Based Fmri; High-Field MRI Systems
6) By Other Products: Magnetoencephalography (MEG) Systems; Near-Infrared Spectroscopy (NIRS) Devices; Transcranial Magnetic Stimulation (TMS) Systems
Companies Mentioned: Siemens Healthineers; GE Healthcare; Philips Healthcare; Elekta AB; Nihon Kohden Corporation; Brainlab AG; Natus Medical Incorporated; Hitachi Medical Systems; Canon Medical Systems Corporation; Compumedics Limited; Medtronic PLC; Magstim Company Limited; EB Neuro S.p.A.; Brain Products GmbH; Soterix Medical Inc.; Rogue Research Inc.; NIRx Medical Technologies LLC; Neurosoft; Artinis Medical Systems; Gowerlabs Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Brain Mapping Instruments market report include:- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
- Elekta AB
- Nihon Kohden Corporation
- Brainlab AG
- Natus Medical Incorporated
- Hitachi Medical Systems
- Canon Medical Systems Corporation
- Compumedics Limited
- Medtronic PLC
- Magstim Company Limited
- EB Neuro S.p.A.
- Brain Products GmbH
- Soterix Medical Inc.
- Rogue Research Inc.
- NIRx Medical Technologies LLC
- Neurosoft
- Artinis Medical Systems
- Gowerlabs Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.58 Billion |
| Forecasted Market Value ( USD | $ 3.33 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
